Fortress Biotech Inc (FBIO)’s Market Momentum: Closing Strong at 1.49, Up 2.76

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Fortress Biotech Inc’s stock clocked out at $1.49, up 2.76% from its previous closing price of $1.45. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.81 million shares were traded. FBIO stock price reached its highest trading level at $1.5199 during the session, while it also had its lowest trading level at $1.46.

Ratios:

To gain a deeper understanding of FBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 4.95 whereas as Long-Term Debt/Eq ratio is at 4.64.

On August 04, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $6.

On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.The Benchmark Company initiated its Buy rating on October 02, 2020, with a $9 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 23 ’24 when ROSENWALD LINDSAY A MD bought 763,359 shares for $1.84 per share. The transaction valued at 1,404,581 led to the insider holds 3,657,264 shares of the business.

ROSENWALD LINDSAY A MD bought 5,000 shares of FBIO for $37,418 on Jul 11 ’24. The President, CEO & Chairman now owns 127,500 shares after completing the transaction at $7.48 per share. On Jul 10 ’24, another insider, Jin David, who serves as the Chief Financial Officer of the company, bought 500 shares for $7.50 each. As a result, the insider paid 3,750 and bolstered with 500 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 33992860 and an Enterprise Value of 13741791. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 0.166 whereas that against EBITDA is -0.152.

Stock Price History:

Over the past 52 weeks, FBIO has reached a high of $5.25, while it has fallen to a 52-week low of $1.24. The 50-Day Moving Average of the stock is -23.05%, while the 200-Day Moving Average is calculated to be -24.88%.

Shares Statistics:

It appears that FBIO traded 407.15K shares on average per day over the past three months and 1225500 shares per day over the past ten days. A total of 26.79M shares are outstanding, with a floating share count of 20.23M. Insiders hold about 21.13% of the company’s shares, while institutions hold 13.53% stake in the company. Shares short for FBIO as of 1726185600 were 2166969 with a Short Ratio of 5.32, compared to 1723680000 on 1611476. Therefore, it implies a Short% of Shares Outstanding of 2166969 and a Short% of Float of 12.0.

Most Popular